Exp Neurol (2010) 224:51726 10.1016/j.expneurol.2010.05.015 [DOI] [PubMed] [Google Scholar] 130.Villar-Cheda B, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL
In SURMOUNT-1 , a 72-week Phase 3 double-blind trial in 2,539 adults with obesity (or overweight with a complication) but without diabetes, once-weekly tirzepatide produced mean weight changes of 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) versus 3.1% with placebo, with 5057% of participants on the higher doses losing at least 20% of body weight
Archived from the original on 2009-07-01
do not shake vigorously Allow the solution to sit until fully dissolved (may take several minutes) For precise concentration calculations based on your reconstitution volume, use our free Peptide Reconstitution Calculator